Johnson and Johnson ordered to pay €4bn to women who developed ovarian cancer

An American drugs giant has been ordered to pay out almost €4bn to several women who developed ovarian cancer.

Johnson and Johnson ordered to pay €4bn to women who developed ovarian cancer

An American drugs giant has been ordered to pay out almost €4bn to several women who developed ovarian cancer.

A case was brought against Johnson and Johnson, which is accused of selling talc powder containing asbestos - something the firm denies.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited